Randomization and placebo effects in clinical trials of major depressive disorder
Saved in:
Main Authors: | James A. Rogers, Stephen Senn |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-025-03263-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beneficial and harmful effects of duloxetine versus placebo, ‘active placebo’ or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
by: Christian Gluud, et al.
Published: (2025-02-01) -
The effect of probiotic-fortified kefir on depression, appetite, oxidative stress, and inflammatory parameters in Iranian overweight and obese elderly: a randomized, double-blind, placebo-controlled clinical trial
by: Mehran Noori, et al.
Published: (2025-02-01) -
Study of Life Events and Quality of Life in Patients of Major Depressive Disorder
by: Alkesh Patil, et al.
Published: (2025-01-01) -
Effect of remote ischemic preconditioning on perioperative neurocognitive disorder in elderly patients undergoing major surgery and associated genetic variant analysis: a randomized clinical trial
by: Feifei Xu, et al.
Published: (2025-02-01) -
Classification of schizophrenia, bipolar disorder and major depressive disorder with comorbid traits and deep learning algorithms
by: Xiangning Chen, et al.
Published: (2025-02-01)